{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-032352","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2026-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.844129+00:00","generated_at":"2026-05-15T09:31:20.928507+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"60 Degrees Pharmaceuticals corrects beneficial ownership disclosure in March 13 prospectus","bullets":["March 13 prospectus supplement incorrectly reported affiliate's beneficial ownership as 21,490 shares; correct is 23,367.","Error originated from a September 2025 Form 4 and propagated through subsequent filings.","Post-1-for-4 reverse split, corrected affiliate ownership is 16,781 shares vs previously reported 15,905.","No other information in the March 13 prospectus supplement is affected by this correction."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-032352","json":"https://secwatch.observer/filing/0001213900-26-032352.json","markdown":"https://secwatch.observer/filing/0001213900-26-032352.md","text":"https://secwatch.observer/filing/0001213900-26-032352.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390026032352/0001213900-26-032352-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390026032352/ea0282850-8k_60degrees.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:31:20.928507+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}